Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep;40(9):1129-1137.
doi: 10.1038/s41401-019-0281-1. Epub 2019 Aug 1.

Overview of Recent Advances in Liposomal Nanoparticle-Based Cancer Immunotherapy

Affiliations
Review

Overview of Recent Advances in Liposomal Nanoparticle-Based Cancer Immunotherapy

Ang Gao et al. Acta Pharmacol Sin. .

Abstract

The clinical performance of conventional cancer therapy approaches (surgery, radiotherapy, and chemotherapy) has been challenged by tumor metastasis and recurrence that is mainly responsible for cancer-caused mortalities. The cancer immunotherapy is being emerged nowadays as a promising therapeutic modality in order to achieve a highly efficient therapeutic performance while circumventing tumor metastasis and relapse. Liposomal nanoparticles (NPs) may serve as an ideal platform for systemic delivery of the immune modulators. In this review, we summarize the cutting-edge progresses in liposomal NPs for cancer immunotherapy, with focus on dendritic cells, T cells, tumor cells, natural killer cells, and macrophages. The review highlights the major challenges and provides a perspective regarding the clinical translation of liposomal nanoparticle-based immunotherapy.

Keywords: T cells; dendritic cells; immunotherapy; liposomal NPs; macrophages; nanomedicine; natural killer cells; tumor cells.

Similar articles

See all similar articles

Cited by 2 articles

LinkOut - more resources

Feedback